IDEX (NYSE:IEX) Releases Quarterly Earnings Results, Beats Estimates By $0.21 EPS

IDEX (NYSE:IEX) announced its quarterly earnings results on Wednesday. The industrial products company reported $2.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.79 by $0.21, FiscalAI reports. IDEX had a net margin of 13.98% and a return on equity of 15.03%. The company had revenue of $886.90 million during the quarter, compared to the consensus estimate of $845.75 million. During the same quarter in the previous year, the company posted $1.75 earnings per share. The company’s revenue for the quarter was up 8.9% compared to the same quarter last year. IDEX updated its Q2 2026 guidance to 2.070-2.120 EPS and its FY 2026 guidance to 8.350-8.550 EPS.

Here are the key takeaways from IDEX’s conference call:

• Q1 beat and guidance raised: IDEX reported organic sales up 5%, Adjusted EBITDA margin of 26% (+50 bps YoY) and orders +10% organically, and raised full‑year organic growth to 3%–4% with Adjusted EPS now $8.35–$8.55.
• HST outperformance and backlog build: Health & Science Technologies drove momentum with orders +17% and organic revenue +11%, 100 bps margin expansion and a stronger backlog that management says increases visibility into growth into 2027 across data center, semiconductor and space & defense markets.
• Mixed performance in short‑cycle segments — FMT and FSDP lagging: FMT orders were +9% but sales only +2% (margin down 10 bps) and FSDP orders fell 4% with sales down 1%; management is forecasting flattish growth for these segments, which limits near‑term consolidated upside.
• Capital allocation and liquidity intact: IDEX repurchased $76M of stock in Q1 (plans to maintain quarterly pace), generated $86M FCF in the seasonally weak quarter, finished with ~2x gross leverage and an active bolt‑on M&A pipeline while keeping buybacks and dividends.

IDEX Price Performance

IDEX stock traded up $11.54 during midday trading on Wednesday, hitting $216.90. The company’s stock had a trading volume of 1,505,642 shares, compared to its average volume of 826,034. The company has a quick ratio of 2.02, a current ratio of 2.86 and a debt-to-equity ratio of 0.45. The stock’s 50-day moving average price is $198.78 and its 200-day moving average price is $187.55. IDEX has a 12 month low of $157.25 and a 12 month high of $223.85. The company has a market capitalization of $16.13 billion, a PE ratio of 33.84, a price-to-earnings-growth ratio of 2.10 and a beta of 0.99.

Institutional Investors Weigh In On IDEX

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Primecap Management Co. CA raised its position in IDEX by 86.5% in the fourth quarter. Primecap Management Co. CA now owns 3,226,787 shares of the industrial products company’s stock worth $574,174,000 after acquiring an additional 1,496,207 shares in the last quarter. State Street Corp raised its position in IDEX by 0.6% in the fourth quarter. State Street Corp now owns 3,172,410 shares of the industrial products company’s stock worth $564,499,000 after acquiring an additional 17,668 shares in the last quarter. Invesco Ltd. raised its position in IDEX by 16.1% in the third quarter. Invesco Ltd. now owns 1,809,788 shares of the industrial products company’s stock worth $294,561,000 after acquiring an additional 250,447 shares in the last quarter. Amundi raised its position in IDEX by 18.7% in the third quarter. Amundi now owns 1,517,903 shares of the industrial products company’s stock worth $248,751,000 after acquiring an additional 239,215 shares in the last quarter. Finally, Dodge & Cox raised its position in IDEX by 266.7% in the fourth quarter. Dodge & Cox now owns 1,262,550 shares of the industrial products company’s stock worth $224,658,000 after acquiring an additional 918,208 shares in the last quarter. 97.96% of the stock is currently owned by institutional investors.

Key Stories Impacting IDEX

Here are the key news stories impacting IDEX this week:

• Positive Sentiment: IDEX beat Q1 estimates and raised guidance — Q1 revenue was $886.9M (≈ +8.9% YoY) and adjusted diluted EPS was $2.00, topping expectations; management raised FY 2026 adjusted EPS guidance to $8.35–8.55 (above consensus) and gave Q2 EPS guidance of $2.07–2.12, which frames near‑term momentum. Read More.
• Positive Sentiment: Management cited strong AI/data‑center demand — Reuters highlights that elevated demand from AI and data‑center customers helped justify the higher profit forecast, a secular tailwind that can sustain higher margins and growth. Read More.
• Positive Sentiment: Analyst targets and sentiment skew positive — recent analyst coverage shows multiple price targets above the current level (median near $241), implying upside if execution continues. That supportive research likely amplified investor buying after the beat. Read More.
• Neutral Sentiment: Earnings call / transcript available for deeper color — the investor presentation and call transcript give more detail on end‑market demand, backlog, and margin drivers for active investors wanting to verify sustainability of the beat. Read More.
• Neutral Sentiment: Market activity and technicals — intraday volume is running above average and the stock is trading above both its 50‑ and 200‑day moving averages, which can attract momentum flows; monitor volume if you’re timing entries/exits. Read More.
• Negative Sentiment: Institutional position shifts are mixed — while many funds hold IEX, some large managers reduced exposure heavily in the prior quarter (e.g., UBS AM), a sign that some large holders may take profits or rebalance into other themes. This could limit upside if selling resumes. Read More.

Analyst Ratings Changes

IEX has been the subject of several research analyst reports. DA Davidson upped their price objective on shares of IDEX from $180.00 to $195.00 and gave the stock a “neutral” rating in a report on Thursday, February 5th. Robert W. Baird set a $247.00 price objective on shares of IDEX in a report on Thursday, February 5th. Oppenheimer reaffirmed an “outperform” rating and issued a $230.00 price objective on shares of IDEX in a report on Thursday, February 5th. Argus raised shares of IDEX from a “hold” rating to a “buy” rating and set a $240.00 price objective for the company in a report on Friday, February 6th. Finally, Royal Bank Of Canada upped their price objective on shares of IDEX from $211.00 to $244.00 and gave the stock an “outperform” rating in a report on Thursday, February 5th. Six analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $228.90.

IDEX Company Profile

IDEX Corporation is a diversified industrial manufacturer specializing in the design, production and distribution of highly engineered fluidics systems, measurement technologies and safety solutions. The company’s core offerings include positive-displacement pumps, flow meters, valves, sampling systems and analytical instruments that serve a wide range of end markets such as water treatment, chemical processing, energy, food and beverage, and life sciences. Through its focus on precision engineering and proprietary material science, IDEX delivers products designed for reliability in demanding applications.

Operations at IDEX are organized into three principal segments.